Mylan Laboratories Ltd.

Pfizer has partnered with Mylan for marketing and supply of Ativan and Pacitane in India. The agreement aims to enhance distribution and in-clinic presence of the products.

Glenmark Pharmaceuticals's US arm has launched a generic version of Clindamycin Phosphate foam, an antibiotic acne treatment. The drug is bioequivalent to Evoclin foam 1 percent and achieved annual...

Mylan Pharmaceuticals Inc. and Novo Nordisk have reached a settlement in the US over a patent infringement lawsuit regarding generic Ozempic, a drug used for blood sugar and weight loss.

Akums Drugs shares listed on BSE and NSE with a 7% premium over the issue price, drawing strong investor interest. The IPO was oversubscribed 63 times.

Akums Drugs and Pharmaceuticals' IPO received 63.56 times subscription on the final day, with strong participation from institutional investors. The IPO was a combination of a fresh issue and an...

Bosch Ltd has been issued a demand notice of over Rs 20 crore by the Income Tax department for the assessment year 2022-2023. The company plans to appeal the assessment order.

Tata Group's Croma appoints Shibashish Roy as its new CEO & MD, effective April 1. Roy brings over 20 years of experience in Tata Group companies and a digital-first approach to customer engagement.

Replus, a Pune-based battery manufacturer, plans to expand its production capacity to 6 GWh by FY26 to meet the growing demand for electric vehicles and energy storage systems in India.

Finance Minister Nirmala Sitharaman launches 'NITI NCAER States Economic Forum' portal providing access to comprehensive data on states' social, economic, and fiscal parameters.

Ajay Anand, Senior VP at Johnson & Johnson, joins Wharton's AI & Analytics Initiative, bringing industry expertise to advise faculty and mentor students.

Bosch Ltd has been issued a demand notice of over Rs 20 crore by the Income Tax department for the assessment year 2022-2023. The company plans to appeal the assessment order.

Tata Group's Croma appoints Shibashish Roy as its new CEO & MD, effective April 1. Roy brings over 20 years of experience in Tata Group companies and a digital-first approach to customer engagement.

Replus, a Pune-based battery manufacturer, plans to expand its production capacity to 6 GWh by FY26 to meet the growing demand for electric vehicles and energy storage systems in India.

Bombay HC rules that mediclaim policy payouts cannot be deducted from medical expenses compensation under the Motor Vehicles Act. Full bench clarifies on double compensation.

Finance Minister Nirmala Sitharaman launches 'NITI NCAER States Economic Forum' portal providing access to comprehensive data on states' social, economic, and fiscal parameters.